CEO Managing Director Presentation to Annual General Meeting
· Issued by Amplia Therapeutics Ltd. via ASX
Filed with ASX · · 19 pages · English
Release
ABN 16 165 160 841
+61 (0) 3 9123 1140 | [email protected]
Level 5, 90 William Street, Melbourne VIC 3000 Australia
www.ampliatx.com
28 AUGUST 2026
ASX RELEASE
CEO & MANAGING DIRECTOR’S PRESENTATION TO ANNUAL GENERAL MEETING
Melbourne, Australia: Amplia Therapeutics...
Amplia Therapeutics Ltd. on 6ix
